Evidence map›Paper›PMID 40565129›Full record

ArticleInternational journal of molecular sciences2025

Increased O-GlcNAcylation in Leukocytes from Overweight Pediatric Subjects: A Pilot Study.

Alessia Remigante, Sara Spinelli, Gianluca Rizzo, Daniele Caruso, Angela Marino, Elisabetta Straface, Silvia Dossena, Rossana Morabito

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessia RemiganteDepartment of Biomedical, Dental and Morphological and Functional Imaging, University of Messina, 98125 Messina, Italy.ORCID 0000-0001-9934-293X
Sara SpinelliDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98125 Messina, Italy.
Gianluca RizzoIndependent Researcher, 98121 Messina, Italy.ORCID 0000-0002-5540-0621
Daniele CarusoComplex Operational Unit of Clinical Pathology of Papardo Hospital, 98166 Messina, Italy.
Angela MarinoDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98125 Messina, Italy.ORCID 0000-0002-6827-7327
Elisabetta StrafaceBiomarkers Unit, Center for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-0784-9077
Silvia DossenaInstitute of Pharmacology and Toxicology, Research and Innovation Center Regenerative Medicine & Novel Therapies, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-6694-9249
Rossana MorabitoDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98125 Messina, Italy.ORCID 0000-0003-4904-4963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type II diabetes mellitus (T2D) is a metabolic disorder. Childhood overweight or obesity raises the risk for developing T2D later in life. Early identification of at-risk individuals is fundamental for disease prevention and patient management. The scope of this pilot study was to explore whether leukocyte protein O-GlcNAc modification is elevated in an overweight pediatric cohort. Eight overweight and eight normal-weight children aged 3-13 years were recruited at the Papardo General Hospital (Messina, Italy). Physical exams, complete blood tests, and determination of leukocyte protein O-GlcNAcylation were carried out. Protein O-GlcNAcylation was higher in leucocytes from overweight children compared to normal-weight children, and was significantly correlated with BMI, metabolic markers (LDL-cholesterol/triglycerides), and the inflammatory marker CRP. This study suggests that leukocyte protein O-GlcNAcylation may represent a novel biomarker for the early detection of metabolic abnormalities that may lead to the development of pre-diabetes or T2D later in life.

Indexed as

AcetylglucosamineLeukocytesOverweightPediatric ObesityAdolescentBiomarkersBody Mass IndexChildChild, PreschoolDiabetes Mellitus, Type 2FemaleHumansMalePilot ProjectsAcetylglucosamineBiomarkersleukocytesO-GlcNAcylationpediatric overweightpre-diabetestype II diabetes mellitus

Identifiers

PMID40565129
PMCPMC12193343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.